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Abstract
Infections are major complications in peritoneal dialysis (PD) with a multifactorial etiology
that comprises patient, microbial and dialytic factors. This study aimed at investigating the
contribution of microbial biofilms on PD catheters to recalcitrant infections and their interplay
with PD related-factors. A prospective observational study was performed on 47 patients
attending Centro Hospitalar of Porto and Vila Nova de Gaia/Espinho to whom the catheter
was removed due to infectious (n = 16) and non-infectious causes (n = 31). Microbial den-
sity on the catheter was assessed by culture methods and the isolated microorganisms
identified by matrix-assisted laser desorption/ionization time-of-flight intact cell mass spec-
trometry. The effect of conventional and three biocompatible PD solutions on 16 Coagulase
Negative Staphylococci (CNS) and 10 Pseudomonas aeruginosa strains planktonic growth
and biofilm formation was evaluated. Cultures were positive in 87.5% of the catheters
removed due infectious and 90.3% removed due to non-infectious causes. However, micro-
bial yields were higher on the cuffs of catheters removed due to infection vs. non-infection.
Staphylococci (CNS and Staphylococcus aureus) and P. aeruginosa were the predominant
species: 32% and 20% in the infection and 43.3% and 22.7% in the non-infection group,
respectively. In general, PD solutions had a detrimental effect on planktonic CNS and P.
aeruginosa strains growth. All strains formed biofilms in the presence of PD solutions. The
solutions had a more detrimental effect on P. aeruginosa than CNS strains. No major differ-
ences were observed between conventional and biocompatible solutions, although in ico-
dextrin solution biofilm biomass was lower than in bicarbonate/lactate solution. Overall, we
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show that microbial biofilm is universal in PD catheters with the subclinical menace of
Staphylococci and P. aeruginosa. Cuffs colonization may significantly contribute to infec-
tion. PD solutions differentially impact microbial species. This knowledge is important for
the development of infection diagnosis, treatment and preventive strategies.
Introduction
Peritoneal dialysis (PD) is a beneficial therapeutic option for end-stage renal disease patients,
with favourable survival outcomes in comparison with hemodialysis [1]. However, infections
are major complications of PD. Catheter (exit-site/ tunnel) infections, ranging between 0.11–
0.93 episodes/patient-year [2], are associated with high risk of developing catheter-related peri-
tonitis [3]. Therefore, 15–57% of these episodes result in catheter removal and technique failure
[4]. Peritonitis, ranging between 0.06–1.66 episodes/patient-year, is responsible for ~20% of
the cases of PD discontinuation, also contributing to residual renal function loss, long-term
peritoneal membrane injury and 2–6% of deaths [5]. Although until a few years ago the inci-
dence of PD infections decreased significantly [6] due to technique improvements and patients
care, nowadays only modest improvements are observed in cure and catheter salvage [7].
Indeed, 20–30% of the catheter-related infections are not cured [8], leading to chronic
infections.
The pathogenesis of catheter-related infections depends on the interplay between patient,
microbial and dialytic factors.
First, the population factors associated with these infections are not clear, although gender,
time on PD [9], age [10] or uraemia [11] have been highlighted as potential risk factors.
Second, chronic infections have been associated with specific microorganisms. Relapsing
peritonitis (same microorganism or culture-negative episode within 4 weeks of completion of
therapy for a prior episode) has been associated with Pseudomonas [10] or Staphylococci
(Coagulase-Negative Staphylococci, CNS, and Staphylococcus aureus) [11]. Recurrent peritoni-
tis (different microorganism within 4 weeks of completion of therapy for a prior episode) has
been associated with Enterococcus species, Gram-negative microorganisms, polymicrobial cul-
tures [10] or fungi [11]. Repeat peritonitis (same microorganism occurring more than 4 weeks
after completion of therapy for a prior episode) has been associated with Staphylococci [12,
13]. It has been suggested that microorganisms can develop antimicrobial resistance during
treatment course or exhibit distinct virulence factors, as biofilm formation ability. Biofilms are
communities of microorganisms adhered to a surface and enmeshed in an extracellular matrix
of microbial and host-derived components. In contrast to cells in suspension (i.e., planktonic),
this protective phenotype enables microorganisms to evade the immune system and to gain tol-
erance to antimicrobial drugs. Furthermore, microorganisms on biofilms can be sloughed, con-
tributing to the persistence of the infection [14]. Biofilms in PD catheters have been
demonstrated by microscopy and culture methods [15] and indirectly by the presence of DNA
fragments on the dialysis fluid [16]. It should be noted that although the presence of biofilms
in PD catheters is generally accepted, its clinical significance is not understood [17].
Third, the impact of dialytic factors on these recalcitrant infections is poorly investigated.
However, automatic PD (APD) has been associated with a reduced risk of developing a first
Gram-positive peritonitis but with higher risk of Gram-negative peritonitis vs. continuous
ambulatory PD (CAPD) [18]. On the other hand, PD solutions are critical for solute and elec-
trolyte exchanges. Lately, conventional solutions (acidic, with lactate, high glucose
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concentration and high level of glucose breakdown products) have started to be replaced by
biocompatible solutions with a neutral pH, bicarbonate or lactate/bicarbonate and low glucose
or icodextrin, presenting low/medium glucose breakdown products [19]. Current evidences do
not conclusively support benefits of the use of biocompatible solutions on peritonitis outcomes
[20]. Both types of solutions have been suggested to inhibit planktonic microorganisms growth.
Conventional solutions do not impair biofilm formation [15], but it is not known how biocom-
patible solutions affect this parameter.
Due to the relevance of PD catheter-related infections and the remarkable lack of under-
standing of the contribution of biofilms to their pathogenesis, this laboratory study evaluated
(i) the microbial density and etiology of biofilms on PD catheters in patients with and without
infection, (ii) infection-associated patient factors and (iii) the impact of PD solutions on micro-
organisms’ survival.
Material and Methods
Population
This study was approved by the Ethics Committee of Centro Hospitalar do Porto [243/11
(153-DEFI/229-CES)] and was performed in accordance with Declaration of Helsinki [21].
The International Society for Peritoneal Dialysis infection criteria were applied [17]. Between
September 2011 and June 2013, we included 47 patients on PD at the Division of Nephrology
of Centro Hospitalar do Porto-Hospital Santo Antonio and Vila Nova Gaia/Espinho whose
catheter was removed by clinical decision (S1 Table). Patients provided written informed con-
sent. Population characteristics and microorganisms recovered from the exit-site/tunnel and/
or peritoneal fluid were obtained from medical records. All patients with infection received
appropriated treatment prior to catheter removal. All catheters were removed in a surgical
environment, divided into external, intraperitoneal segments, subcutaneous and deep cuff (Fig
1A), placed separately in sterile bags and transported at 4°C for microbiological processing on
the same day.
Microbial density and species on catheter segments
The isolation protocol was designed in order to recover the microorganisms most frequently
associated with infections. External segments outer surface was disinfected with ethanol as pre-
viously described [22]. The segment was split longitudinally and the biomass on the inner sur-
face recovered by scrapping and resuspended in 400 μL of Tryptic Soy Broth (TSB, Liofilchem).
Intraperitoneal segments were split longitudinally, cut in pieces and placed in TSB (4 mL).
Cuffs were placed in TSB (4 mL). All the suspensions were sonicated at 50–60 Hz (Sonicor) dur-
ing 5 min and vortexed for 30 s. For semi-quantitative analysis, 100 μL of the suspension was
plated onto Tryptose Blood Agar Base (Oxoid)-7% defibrinated sheep blood (Probiologica)
(TBA) and incubated at 37°C, 72 h. The remaining suspension was inoculated in additional 5
mL of TSB—7% defibrinated sheep blood and incubated at 37°C, 120 rpm for 24 h, followed by
subculturing on TBA at 37°C, up to 72 h. Two independent researchers recorded the number of
colony forming units (CFU), examined the colonies features (for elevation and margin) and
picked up several colonies for further identification. The detection limits were of 4 CFU/ exter-
nal segment and of 40 CFU/ intraperitoneal segment or cuff.
All the isolated microorganisms were identified by matrix-assisted laser desorption/ioniza-
tion time-of-flight intact cell mass spectrometry (MALDI-TOF-ICMS). Briefly, all the strains
were grown in TBA at 37°C for 24 h. The sample was prepared by the direct transfer procedure,
consisting on the smear of one colony in a well of the target plate and mixing it with 0.5 μL of
the MALDI matrix solution [75 mg/ml 2,5-dihydroxybenzoic acid (Sigma) in ethanol (Sigma)
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/water/acetonitrile (Sigma) [1:1:1] with 0.03% trifluoroacetic acid (Sigma)]. The sample was
allowed to dry at room temperature. All the analyses were carried out on an Axima LNR system
(Kratos Analytical, Shimadzu) equipped with a nitrogen laser (337 nm). Final spectra were
generated within the mass range m/z = 2,000 to 20,000 Da, using the linear mode. Escherichia
coli DH-5α ribosomal proteins were used for external calibration of the spectra. Microbial
identification was performed on the SARAMIS software (AnagnosTec GmbH). The identifica-
tion was automatically performed by comparison of the ions list of individual samples against
the SuperSpectra. Results were considered acceptable for confidence levels 70%.
Effect of PD solutions on catheter recovered strains
Four PD solutions formulations were used: three biocompatible solutions: (i) icodextrin [acidic
pH, lactate buffered-icodextrin (7.5%)], (ii) bicarbonate/lactate [neutral pH, bicarbonate/lac-
tate buffered-glucose (1.4%)], (iii) bicarbonate [neutral pH, bicarbonate buffered-glucose
(1.5%)], and a conventional solution [acidic pH, lactate buffered-glucose (1.5%)] was used as a
control.
Fig 1. PD catheters. Schematic diagram of the catheter segments including the silicone based segments:
external (a) and intraperitoneal (d) and the cuffs: subcutaneous (b) and deep (c) (left). The different segments
were cultured separately. Therefore, a Venn diagram (right) illustrates the possible relationships among them
(external segment in red, subcutaneous cuff in yellow, deep cuff in blue and intraperitoneal segment in green)
(A). The representation of the distribution and overlap of positive segment cultures in catheters removed from
patients with (left) and without infection (right) (B). Values represent the number of catheters with a specific
catheter colonization pattern. Four patients had growth on all catheter segments—with refractory and fungal
(n = 3) and catheter-related peritonitis (n = 1); 2 patients had growth on the catheter subcutaneous and deep
cuffs—with relapsing peritonitis (n = 1) and chronic catheter infection (n = 1); 3 patients had growth only on
the catheter deep cuff—with relapsing peritonitis (n = 1) and chronic catheter infection (n = 2); 2 patients had
growth on the catheter deep cuff and intraperitoneal segment—with chronic catheter infection; 3 patients had
growth on the catheter subcutaneous and deep cuffs and intraperitoneal segment—with catheter-related
peritonitis (n = 1), chronic catheter infection (n = 2). At the time of removal, §2 and *, 1 catheter did not present
subcutaneous cuff.
doi:10.1371/journal.pone.0157870.g001
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P. aeruginosa (PD21.5, 26.4, 30.4, 37.1, 42.4, 50.2, 64.8, 68.7, 82.5, 96.4) and CNS, S. epider-
midis (PD6, 10.2, 11.4, 20.8, 36.1, 45.8, 62.7, 64.6, 85.8, 97), S. caprae/capitis (PD42.5, 81.1), S.
haemolyticus (PD10.1, 20.7, 50.1) and S. hominis (PD37.7) isolated in this study were tested. A
saline suspension of each strain previously grown in Tryptic Soy Agar (TSA, Liofilchem) at
37°C, 18 h was prepared. The density was adjusted to that of McFarland 0.5 standard and
diluted to ~1 x 107 CFU/mL.
Planktonic cells and biofilms were grown as previously described [23]. Ninety-six-wells
microtiter plates were conditioned with 150 μL of each PD solution at 37°C, 5% CO2 for 24 h.
The PD solutions were then aspirated. Standardized bacterial suspensions were added (150 μL/
well) and incubated at 37°C, 5% CO2 for 24 h. The medium containing planktonic cells was
collected and sonicated at 50–60 Hz for 5 min. The biofilms on the wells were washed with
saline. Biofilm cells were recovered in 150 µL of TSB-1% (v/v) Tween-20 (Sigma) after 20 min
sonication at 50–60 Hz. Viable counts were obtained by serial dilution, and plating on TSA.
CFU were enumerated after 24 h at 37°C. Biofilm biomass was determined by the crystal violet
assay. Biofilms were stained with 150 μL of crystal violet 10 g/l [1% (w/v) crystal violet
(Merck)] for 5 min. The stain was then aspirated and each well was washed twice with ultra-
pure water, air dried for 20 min and destained with 150 μL of ethanol 100%. Next, 100 μL of
the destaining solution was transferred to a new microtiter plate and the absorbance at 570nm
(Abs570nm) was recorded (Tecan, Sunrise). TSB and saline were used as positive and negative
growth controls, respectively. Two independent assays with four to eight replicates were
performed.
Statistical analyses
Mann-Whitney's test was used for continuous variables and chi-square test with Yates' correc-
tion or Fisher's exact test for categorical variables. Whenever appropriate, odds ratio (OR) and
95% confidence intervals (CI) were determined. Heat maps were generated using CIMminer
one matrix [24] with the Euclidean distance method and Ward cluster algorithm. Based on the
clusters obtained, group comparisons were performed using Mann-Whitney's test or Dunn's
multiple comparisons test. P< 0.05 was considered statistically significant. Correlation between
the microbial burden and catheter in situ time techniques was determined using linear regres-
sion. Statistical analysis was performed using GraphPad Prism.
Results
Study population
The PD catheter can be divided in four segments: the external segment (Fig 1Aa)–that is out-
side the body -, the subcutaneous (Fig 1Ab) and deep cuff (Fig 1Ac)–tunneled segments that
transverse the abdominal wall acting as mechanical anchors at two different points–, and the
intraperitoneal segment with multiple small openings and the majority of times is coiled (Fig
1Ad)–that is inside the peritoneal cavity. In this study, forty-seven catheters were examined: 16
from patients with infection and 31 from patients without infection (S1 Table). All active
patients had a Y-set system and were on neutral pH, low glucose breakdown products—bio-
compatible solutions. In this population, chronic infections were more likely to be associated
with older patients ( 55 years old) and a history of previous infection (Table 1).
Characteristics of biofilms on PD catheters
The literature suggests that the colonization differs among the different segments (e.g. [25]).
Therefore, in this study we analysed each segment separately. Catheters culture was positive for
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any segment in 87.5% (n = 14) of those removed from patients with infection and in 90.3%
(n = 28) without infection (OR, 0.75; CI, 0.11–5.02; P = 1). Furthermore, the distribution of
positive cultures along the catheter was similar in both groups (Fig 1B, P = 0.72). However, the
analyses of the microbial yield revealed that the colonization level in the cuffs (Fig 2C and 2D)
is higher in catheters removed due to infectious vs. non-infectious causes: 2600 vs. 60 CFU/
subcutaneous cuff and 280 vs. 40 CFU/deep cuff (infection vs. absence of infection, P = 0.01; S2
Table). Notably, in both groups the median microbial yield was higher in the cuffs (Fig 2C and
2D) than in the silicone segments (Fig 2A and 2B): infection group, 720 CFU/cuffs vs. 20 CFU/
silicone segment, P< 0.0001; and absence of infection group, 40 CFU/cuffs vs. 20 CFU/silicone
segment, P< 0.0001], thus pointing to subclinical colonization of the cuffs. In this population
there was no correlation between microbial burden and catheter in situ time (S1 Fig).
Table 1. Clinic and epidemiologic characteristics of the study population.
Variable Infection (n = 16) Absence of infection
(n = 31)
Odds ratio [95% conﬁdence
interval]
P value
Age
 55 years old 12 (75) 13 (41.9) 4.5 [1.19–17] 0.03
< 55 years old 4 (25) 18 (58.1)
Gender
Male 11 (68.8) 19 (61.3) 1.39 [0.39–5.0] 0.75
Female 5 (31.3) 12 (38.7)
Comorbidities
Diabetes mellitus 4 (25) 7 (22.6) 1.14 [0.28–4.68] 1
No diabetes mellitus 12 (70.6) 24 (77.4)
Previous RRT
PD ﬁrst 12 (75) 21 (67.7)
Othera 4 (25) 10 (32.2)
PD modalityb
APD 5 (31.3) 15 (48.4) 0.43 [0.12–1.6] 0.33
CAPD 10 (62.5) 13 (41.9)
Catheter in situ
 50 months 1 (6.3) 10 (32.3) 7.62 [0.88–65.84] 0.07
< 50 months 15 (93.8) 21 (67.7)
History of previous
infections
Peritonitis
n 1 10 (62.5) 8 (25.8) 4.79 [1.31–17.5] 0.02
n = 0 6 (37.5) 23 (74.2)
Catheter infections
n 1 7 (43.8) 4 (12.9) 5.25 [1.24–22.2] 0.03
n = 0 9 (56.2) 27 (87.1)
Etiology of ESRD
Undetermined 0 (0) 7 (22.6) 0.1 [0.005–1.85] 0.08
Othersc 16 (100) 24 (77.4)
a, hemodialysis and renal transplant;
b, 1 patient in the group “Infection” and 3 patients in the group “Absence of infection” were not active/ have not initiated the therapy;
c, Diabetic nephropathy, systemic disease, glomerulonephritis, autosomal dominant polycystic kidney disease, interstitial nephritis, hereditary nephropathy/
malformation. Values are numbers with percentages in parenthesis.
PD, peritoneal dialysis, APD, automatic PD; CAPD, continuous ambulatory PD; ESRD, end-stage renal disease; RRT, renal replacement therapy.
doi:10.1371/journal.pone.0157870.t001
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Fig 2. Microbial yield on PD catheters external (A) and intraperitoneal (B) segments and subcutaneous (C) and deep (D) cuffs in patients
with and without infection. Data is presented as colony-forming units (CFU)/segment with the corresponding microorganisms represented by
specific symbols. dot, coagulase negative Staphylococci (including Staphylococcus epidermidis, S. haemolyticus, S. caprae/ capitis, S. hominis,
S. auricularis); diamond filled, Staphylococcus aureus; square filled, Corynebacterium spp.; down-pointing triangle filled, Micrococcus luteus; up-
pointing triangle filled, Enterococcus faecalis; hexagon filled, Streptococcus spp.; right-pointing triangle filled, Bacillus spp.; circle, Pseudomonas
aeruginosa; square, Sphingomonas spp.; diamond, Alcaligenes faecalis; down-pointing triangle, Serratia marcescens; up-pointing triangle,
Burkholderia sp.; left-pointing triangle, Stenotrophomonas maltophilia; right-pointing triangle, Escherichia coli; crossed out circle, Enterobacter
aerogenes; star, Candida parapsilosis; asterisk, Candida glabrata; circle quartered, non-identified microorganism. Absence of microorganisms is
represented by, vertical line. Polymicrobial cultures are identified with a half tick-up line. In the group “infection” the cause of removal is indicated
as alpha, for refractory peritonitis; beta, for relapsing peritonitis; gamma, fungal peritonitis; delta, for catheter-related peritonitis and epsilon, for
chronic catheter infections. The dashed line indicates the culture method detection limit.
doi:10.1371/journal.pone.0157870.g002
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However, we noticed that in each group the microbial species recovered from the cuffs and
silicone segments were similar (S3 Table). Therefore, we considered the overall microbial spe-
cies recovered from the catheters (Fig 2). In catheters removed due to infectious causes Staphy-
lococci and P. aeruginosa were the predominant species (32% and 20%, respectively) followed
by Corynebacterium spp. =Micrococcus luteus = Streptococcus spp. = Alcaligenes faecalis =
Candida glabrata> S.marcescens> Enterococcus faecalis = Bacillus spp. = Sphingomonas spp.
= Enterobacter aerogenes = Escherichia coli. In 75% of the catheters (n = 12) the infectious caus-
ing agent was recovered, although in 25% of these (n = 3), together with other microorganisms.
However, in the case of two patients with S. aureus and S. xylosus chronic catheter infection,
other microorganisms were found while in two patients with Corynebacterium spp. and P. aer-
uginosa chronic catheter infections, no microorganisms were recovered.
Notably, in catheters removed due to non-infectious causes Staphylococci and P. aeruginosa
were also the predominant species (43.3% and 22.7%, respectively) but then followed by Cory-
nebacterium spp.>M. luteus> Bacillus spp. = Sphingomonas spp.> Burkholderia sp. = Steno-
trophomonas maltophilia = C. parapsilosis.
We also analysed the proportion of the different species found in each catheter (S4 Table).
Curiously, P. aeruginosa and CNS were only co-isolated in the same catheter in the group of
patients without infection, where P. aeruginosa was the dominant species in 6 out of these 9
microbial communities. The presence of these microorganisms was less likely to be associated
with catheters removed due to infectious causes than non-infectious ones (OR, 0.22; CI, 0.08–
0.62; P = 0.005 and OR, 0.22; CI, 0.08–0.62; P = 0.045, respectively), again pointing to a sub-
clinical colonization with these menacing agents.
Impact of PD solutions on microorganisms
Due to the relevance of CNS and P. aeruginosa as colonizers of PD catheters, their involvement
in recalcitrant infections [10–13] and their known ability to form biofilms [26], it is important
to elucidate how dialytic factors affect their survival. Therefore, the effect of three biocompati-
ble PD solutions being used by the patients (biocompatible bicarbonate, bicarbonate/lactate
and icodextrin solutions) was tested on ten P. aeruginosa and 16 CNS (10 S. epidermidis, 2 S.
caprae/capitis, 3 S. haemolyticus and 1 S. hominis) strains previously recovered from the cathe-
ters. A conventional solution was used as a control.
Firstly, we evaluated the effect on planktonic cells (Fig 3, S5 Table). The strains were
resolved in two major groups (Fig 3) comprising P. aeruginosa (G1) and CNS (G2) according
to similarities in their growth profile. PD solutions inhibited the growth of CNS strains that
invariably exhibited significantly lower number of culturable cells vs. the initial inoculum. In
contrast, a less detrimental effect was observed on P. aeruginosa strains that did not grow in
the presence of bicarbonate and bicarbonate/lactate solutions but exhibited slightly higher cell
numbers in conventional and icodextrin solutions. Overall, P. aeruginosa isolates displayed
higher cell densities than CNS after exposure to the solutions (Fig 3; P< 0.0001). Notably, con-
ventional and biocompatible solutions had a similar effect on planktonic cells (P> 0.05).
To determine the effect of PD solutions on biofilms, cell density (Fig 4A, S5 Table) and
whole biofilm biomass (Fig 4B, S5 Table) were evaluated. In the presence of PD solutions all
the strains formed biofilm with 3 × 103 CFU/cm2 (Fig 4A) and biomass 0.01 Abs570/cm2
(Fig 4B), although in a less extent than in the positive control. However, P. aeruginosa exhibited
significantly higher microbial yields and biomass (Fig 4, G1) than CNS strains (Fig 4, G2). In
general, conventional and biocompatible solutions elicited a similar effect on strains biofilm
formation. Nevertheless, strains grown in icodextrin exhibited less biofilm biomass than in
bicarbonate/lactate solutions (P = 0.03), mainly driven by the negative impact of the former
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solution on CNS biomass [0.02 (interquartile range, IQR, 0.02–0.04) vs. 0.07 (IQR, 0.05–0.11)
Abs570nm/cm2, P = 0.008 for CNS; 0.14 (IQR, 0.05–0.23) vs. 0.27 (IQR, 0.15–0.47)
Abs570nm/cm2 for P. aeruginosa; icodextrin vs. bicarbonate/lactate].
Discussion
PD infections management is focused on the elimination of planktonic microorganisms
expected to respond to local antimicrobial therapies. However, a significant amount of cases do
not resolve and require catheter removal [17]. From other fields [27] it is anticipated that bio-
films on catheters threaten the resolution of infections. The recent guidelines for the diagnosis
and treatment of biofilm infections [27] do not make recommendations for PD patients,
demanding a deeper investigation.
Using ex vivo and in vitro microbiological approaches we show that biofilms, highly domi-
nated by Staphylococci and P. aeruginosa, are ubiquitous on PD catheters, although their
Fig 3. Effect of PD solutions on P. aeruginosa and CNS planktonic cells.Mean log CFU/mL after 24 h
exposure to PD solutions was used for the generation of the heat map. The strains are indicated on the right (Pa, P.
aeruginosa; Se, S. epidermidis, Scc, S. caprae/capitis; Sha, S. haemolyticus; Sho, S. hominis). Strains derived
from catheters of patients with infection are indicated with an asterisk. Main strains clusters are identified as group 1
(G1) and group 2 (G2). The conventional and biocompatible (bicarbonate, bicarbonate/lactate, icodextrin) PD
solutions are indicated on the bottom, as well as the growth controls: positive (C+, TSB culture medium) and
negative (C-, saline). The initial inoculum concentration was of ~1 × 107 CFU/mL (7 log CFU/mL). Dendrograms
across the top and left of the heat map show the relationship between PD solutions and strains, respectively.
Distance values are depicted by the gradient colour ranging from green (lowest value) to red (highest value).
doi:10.1371/journal.pone.0157870.g003
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Fig 4. Effect of PD solutions on P. aeruginosa and CNS biofilm cells (A) and biomass, cells and
extracellular matrix (B).Mean log CFU/cm2 (A) and Abs570nm/cm2 (B) after 24 h exposure to PD solutions
were used for the generation of the heat maps. The strains are indicated on the right (Pa, P. aeruginosa; Se,
S. epidermidis, Scc, S. caprae/capitis; Sha, S. haemolyticus; Sho, S. hominis). Strains derived from catheters
of patients with infection are indicated with an asterisk. Main strains clusters are identified as group 1 (G1)
Biofilms in PD Catheters
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microbial burden may allow the discrimination of an infective status. This widespread inci-
dence is supported by PD solutions.
The long-term implantation of the catheter, multiple sources of potential contamination
including manipulation by the patient and the moist environment provide unique conditions
for the establishment of biofilm. We report the presence of culturable microorganisms at the
surfaces of PD catheters (Fig 1) despite the absence of infection, as previously observed. Even
though, in some cases we did not recover microorganisms from the catheter segments, simi-
larly to the observed in catheters removed from patients with or without infection [15]. This
can be due to the presence of unculturable microorganisms, non ability of certain microorgan-
isms to grow under the experimental conditions used, or to the undergoing antimicrobial ther-
apy, in the cases of established infection. Therefore, future studies may include a multi-modal
approach that also includes molecular-based and microscopy approaches [28].
CNS and P. aeruginosa—major threats in PD chronic infections [10–13]—were the domi-
nant microbial species recovered in both groups (Fig 2), in accordance with previous reports
[15]. This suggests that contamination and exit-site/tunnel infections are major players for
microbial entry. It should be noted that the majority of previously studies were performed on
catheters recovered between 1990 and 2000. After that period PD technique and preventive
protocols have changed in parallel with the spectrum of infection causing agents [29]. To the
best of our knowledge, we firstly report the recovery of A. faecalis, Bacillus spp. and S.malto-
philia from PD catheters. While A. faecalis was recovered from the catheter of a patient with an
infection caused by this microorganism, the other two microbial species were recovered from
catheters of patients without infection. This is particularly relevant because these species are
associated with poor prognosis and loss of catheter [30, 31]. Furthermore, it is particularly
interesting that in five catheters removed due to infection other microorganisms besides the
infection agent were found. This strongly suggests a biofilm community supporting the co-
existence of several species contributing to the persistence of the infection, and the need to fur-
ther explore the interactions between the different microorganisms, even in the subclinical
infections.
However, our study is unique in that it compares the microbial density in PD catheters
removed due to infectious and non-infectious causes, while a previous study only reported bur-
den estimates (number of colonies when up to 100 and moderate growth –105–106 CFU/mL—
and heavy pure growth—107–109 CFU/mL) in catheters removed from patients with infection
[25]. We found that microbial burdens are higher on cuffs than silicone segments in the pres-
ence of infection. Indeed, in hemodialysis catheters thicker and highly colonized biofilms have
been associated with infection [32, 33]. Importantly, we show that cuffs are common and sig-
nificant reservoirs of microorganisms in subclinical settings. This is in line with previous obser-
vations of colonization [34] and persistence of bacteria [25] on the cuffs. However, it cannot be
disregarded that the catheter removal cause, initiated antimicrobial treatment and microorgan-
isms’migration along the catheter can be confounding variables. While the same methodology
was used through all the study, the microbiological analysis is semi-quantitative, as the com-
plete recovery of microorganisms from the catheter cannot be assured and some of the micro-
organisms may be unculturable.
and group 2 (G2). The conventional and biocompatible (bicarbonate, bicarbonate/lactate, icodextrin) PD
solutions are indicated on the bottom, as well as the growth controls: positive (C+, TSB culture medium) and
negative (C-, saline). Dendrograms across the top and left of the heat map show the relationship between PD
solutions and strains, respectively. Distance values are depicted by the gradient colour ranging from green
(lowest value) to red (highest value).
doi:10.1371/journal.pone.0157870.g004
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We took advantage of the cohort of microorganisms recovered from PD catheters to study
the short-term effect of biocompatible solutions. Biocompatible solutions are increasingly used
due to promising benefits on the peritoneal membrane [19] but, to date their role on biofilms is
not known. Using in vitro studies, we found that biocompatible solutions restrain the growth
of PD strains in suspension and, as firstly shown here, support biofilm formation, similarly to
conventional solutions (Figs 3 and 4). Icodextrin reduced biofilm biomass vs. bicarbonate/lac-
tate solution, probably due to the lack of glucose as a carbon source in the former solution.
However, this may be overcome by the patient dialysate composition changes that occur during
the day, as described for S. epidermidis with conventional solutions [35]. These results seem to
meet the above-mentioned observations of PD solutions similar outcome on patients’ infection
rates [20]. It was also interesting to find that PD solutions have a more detrimental effect on
CNS than P. aeruginosa strains, what may at least in part underlie the clinical observations that
CNS infections tend to be more benign than P. aeruginosa ones [36, 37]. To get further insights
into the role of microorganisms in infections, it would be interesting to understand the biofilm
forming ability of the strains responsible for the infectious episodes in comparison with the
ones isolates from non-infectious ones in the presence of PD solutions.
These findings suggest that although the biofilm on PD catheter, per se, do not result in
infection, when it reaches a certain density, the patient immune defenses may be overcome
promoting the (re)infection.
In terms of diagnosis, our study calls for biofilm in vivo visualization techniques and estab-
lishment of infectivity cut-offs. Furthermore, we observed that a previous infection was associ-
ated with high risk of chronic infection (Table 1), suggesting inefficient microorganisms
removal or changes in imunomodulatory pathways, predisposing to infection, as previously
anticipated [38]. Therefore, controlled trials that include the assessment of biofilm-associated
immune biomarkers are required, besides the already established infection fingerprints [39].
In terms of treatment, it seems critical to consider the growth and susceptibility of microor-
ganisms on biofilms. This can be achieved estimating the antimicrobial tolerance of biofilm
cells and using it instead of the routine minimal inhibitory concentrations. Although the use of
oral/systemic antimicrobials in PD catheter exit-site management is debated [17], the high col-
onization rates at the cuffs observed herein suggest the need of more aggressive treatments to
overcome the risk of acute-to-chronic infection progression.
In terms of preventive strategies, the high predominance of CNS and P. aeruginosa empha-
sizes the importance of patient training towards aseptic technique of the catheter transfer set
[22] and exit-sites. This should be supported by the development of new catheters that promote
better integration in the abdominal wall. Additionally, strategies aimed at reducing the density
or at resensitising microorganisms on biofilms, should be investigated. Current evidences do
not provide clear benefits of heparin, urokinase, tissue plasminogen activator in chronic PD
infections treatment [17]. However, these and emerging adjunctive therapies, as DNase [40],
can be tested as infection preventive strategies.
Our results show that microbial biofilms are a common feature in PD catheters, whose
extent increases in the presence of infection. This provides insights into the pathogenesis of
chronic PD infections and the foundation of future studies and approaches.
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